IBDEI1Z2 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,31492,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31492,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,fts 2
;;^UTILITY(U,$J,358.3,31492,1,4,0)
;;=4^O36.0112
;;^UTILITY(U,$J,358.3,31492,2)
;;=^5016844
;;^UTILITY(U,$J,358.3,31493,0)
;;=O36.0113^^126^1626^58
;;^UTILITY(U,$J,358.3,31493,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31493,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,fts 3
;;^UTILITY(U,$J,358.3,31493,1,4,0)
;;=4^O36.0113
;;^UTILITY(U,$J,358.3,31493,2)
;;=^5016845
;;^UTILITY(U,$J,358.3,31494,0)
;;=O36.0114^^126^1626^59
;;^UTILITY(U,$J,358.3,31494,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31494,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,fts 4
;;^UTILITY(U,$J,358.3,31494,1,4,0)
;;=4^O36.0114
;;^UTILITY(U,$J,358.3,31494,2)
;;=^5016846
;;^UTILITY(U,$J,358.3,31495,0)
;;=O36.0115^^126^1626^60
;;^UTILITY(U,$J,358.3,31495,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31495,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,fts 5
;;^UTILITY(U,$J,358.3,31495,1,4,0)
;;=4^O36.0115
;;^UTILITY(U,$J,358.3,31495,2)
;;=^5016847
;;^UTILITY(U,$J,358.3,31496,0)
;;=O36.0120^^126^1626^61
;;^UTILITY(U,$J,358.3,31496,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31496,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,unsp fts
;;^UTILITY(U,$J,358.3,31496,1,4,0)
;;=4^O36.0120
;;^UTILITY(U,$J,358.3,31496,2)
;;=^5016849
;;^UTILITY(U,$J,358.3,31497,0)
;;=O36.0121^^126^1626^62
;;^UTILITY(U,$J,358.3,31497,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31497,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 1
;;^UTILITY(U,$J,358.3,31497,1,4,0)
;;=4^O36.0121
;;^UTILITY(U,$J,358.3,31497,2)
;;=^5016850
;;^UTILITY(U,$J,358.3,31498,0)
;;=O36.0122^^126^1626^63
;;^UTILITY(U,$J,358.3,31498,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31498,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 2
;;^UTILITY(U,$J,358.3,31498,1,4,0)
;;=4^O36.0122
;;^UTILITY(U,$J,358.3,31498,2)
;;=^5016851
;;^UTILITY(U,$J,358.3,31499,0)
;;=O36.0123^^126^1626^64
;;^UTILITY(U,$J,358.3,31499,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31499,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 3
;;^UTILITY(U,$J,358.3,31499,1,4,0)
;;=4^O36.0123
;;^UTILITY(U,$J,358.3,31499,2)
;;=^5016852
;;^UTILITY(U,$J,358.3,31500,0)
;;=O36.0124^^126^1626^65
;;^UTILITY(U,$J,358.3,31500,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31500,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 4
;;^UTILITY(U,$J,358.3,31500,1,4,0)
;;=4^O36.0124
;;^UTILITY(U,$J,358.3,31500,2)
;;=^5016853
;;^UTILITY(U,$J,358.3,31501,0)
;;=O36.0125^^126^1626^66
;;^UTILITY(U,$J,358.3,31501,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31501,1,3,0)
;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 5
;;^UTILITY(U,$J,358.3,31501,1,4,0)
;;=4^O36.0125
;;^UTILITY(U,$J,358.3,31501,2)
;;=^5016854
;;^UTILITY(U,$J,358.3,31502,0)
;;=O36.0130^^126^1626^67
;;^UTILITY(U,$J,358.3,31502,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31502,1,3,0)
;;=3^Maternal care for Anti-D antibodies,3rd tri,unsp fts
;;^UTILITY(U,$J,358.3,31502,1,4,0)
;;=4^O36.0130
;;^UTILITY(U,$J,358.3,31502,2)
;;=^5016856
;;^UTILITY(U,$J,358.3,31503,0)
;;=O36.0131^^126^1626^68
;;^UTILITY(U,$J,358.3,31503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31503,1,3,0)
;;=3^Maternal care for Anti-D antibodies,3rd tri,fts 1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1Z2 3798 printed Sep 23, 2025@19:54:36 Page 2
IBDEI1Z2 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,31492,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,31492,1,3,0)
+4 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 2
+5 ;;^UTILITY(U,$J,358.3,31492,1,4,0)
+6 ;;=4^O36.0112
+7 ;;^UTILITY(U,$J,358.3,31492,2)
+8 ;;=^5016844
+9 ;;^UTILITY(U,$J,358.3,31493,0)
+10 ;;=O36.0113^^126^1626^58
+11 ;;^UTILITY(U,$J,358.3,31493,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,31493,1,3,0)
+14 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 3
+15 ;;^UTILITY(U,$J,358.3,31493,1,4,0)
+16 ;;=4^O36.0113
+17 ;;^UTILITY(U,$J,358.3,31493,2)
+18 ;;=^5016845
+19 ;;^UTILITY(U,$J,358.3,31494,0)
+20 ;;=O36.0114^^126^1626^59
+21 ;;^UTILITY(U,$J,358.3,31494,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,31494,1,3,0)
+24 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 4
+25 ;;^UTILITY(U,$J,358.3,31494,1,4,0)
+26 ;;=4^O36.0114
+27 ;;^UTILITY(U,$J,358.3,31494,2)
+28 ;;=^5016846
+29 ;;^UTILITY(U,$J,358.3,31495,0)
+30 ;;=O36.0115^^126^1626^60
+31 ;;^UTILITY(U,$J,358.3,31495,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,31495,1,3,0)
+34 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 5
+35 ;;^UTILITY(U,$J,358.3,31495,1,4,0)
+36 ;;=4^O36.0115
+37 ;;^UTILITY(U,$J,358.3,31495,2)
+38 ;;=^5016847
+39 ;;^UTILITY(U,$J,358.3,31496,0)
+40 ;;=O36.0120^^126^1626^61
+41 ;;^UTILITY(U,$J,358.3,31496,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,31496,1,3,0)
+44 ;;=3^Maternal care for Anti-D antibodies,2nd tri,unsp fts
+45 ;;^UTILITY(U,$J,358.3,31496,1,4,0)
+46 ;;=4^O36.0120
+47 ;;^UTILITY(U,$J,358.3,31496,2)
+48 ;;=^5016849
+49 ;;^UTILITY(U,$J,358.3,31497,0)
+50 ;;=O36.0121^^126^1626^62
+51 ;;^UTILITY(U,$J,358.3,31497,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,31497,1,3,0)
+54 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 1
+55 ;;^UTILITY(U,$J,358.3,31497,1,4,0)
+56 ;;=4^O36.0121
+57 ;;^UTILITY(U,$J,358.3,31497,2)
+58 ;;=^5016850
+59 ;;^UTILITY(U,$J,358.3,31498,0)
+60 ;;=O36.0122^^126^1626^63
+61 ;;^UTILITY(U,$J,358.3,31498,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,31498,1,3,0)
+64 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 2
+65 ;;^UTILITY(U,$J,358.3,31498,1,4,0)
+66 ;;=4^O36.0122
+67 ;;^UTILITY(U,$J,358.3,31498,2)
+68 ;;=^5016851
+69 ;;^UTILITY(U,$J,358.3,31499,0)
+70 ;;=O36.0123^^126^1626^64
+71 ;;^UTILITY(U,$J,358.3,31499,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,31499,1,3,0)
+74 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 3
+75 ;;^UTILITY(U,$J,358.3,31499,1,4,0)
+76 ;;=4^O36.0123
+77 ;;^UTILITY(U,$J,358.3,31499,2)
+78 ;;=^5016852
+79 ;;^UTILITY(U,$J,358.3,31500,0)
+80 ;;=O36.0124^^126^1626^65
+81 ;;^UTILITY(U,$J,358.3,31500,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,31500,1,3,0)
+84 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 4
+85 ;;^UTILITY(U,$J,358.3,31500,1,4,0)
+86 ;;=4^O36.0124
+87 ;;^UTILITY(U,$J,358.3,31500,2)
+88 ;;=^5016853
+89 ;;^UTILITY(U,$J,358.3,31501,0)
+90 ;;=O36.0125^^126^1626^66
+91 ;;^UTILITY(U,$J,358.3,31501,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,31501,1,3,0)
+94 ;;=3^Maternal care for Anti-D antibodies,2nd tri,fts 5
+95 ;;^UTILITY(U,$J,358.3,31501,1,4,0)
+96 ;;=4^O36.0125
+97 ;;^UTILITY(U,$J,358.3,31501,2)
+98 ;;=^5016854
+99 ;;^UTILITY(U,$J,358.3,31502,0)
+100 ;;=O36.0130^^126^1626^67
+101 ;;^UTILITY(U,$J,358.3,31502,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,31502,1,3,0)
+104 ;;=3^Maternal care for Anti-D antibodies,3rd tri,unsp fts
+105 ;;^UTILITY(U,$J,358.3,31502,1,4,0)
+106 ;;=4^O36.0130
+107 ;;^UTILITY(U,$J,358.3,31502,2)
+108 ;;=^5016856
+109 ;;^UTILITY(U,$J,358.3,31503,0)
+110 ;;=O36.0131^^126^1626^68
+111 ;;^UTILITY(U,$J,358.3,31503,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,31503,1,3,0)
+114 ;;=3^Maternal care for Anti-D antibodies,3rd tri,fts 1
